38 related articles for article (PubMed ID: 22779728)
21. Comparison of p16INK4a immunocytochemistry with the HPV polymerase chain reaction in predicting high grade cervical squamous intraepithelial lesions.
Indarti J; Fernando D
Asian Pac J Cancer Prev; 2013; 14(9):4989-92. PubMed ID: 24175764
[TBL] [Abstract][Full Text] [Related]
22. HPV-related vulvar diseases and perspectives of p16INK4a immunochemistry: a review of the literature.
Carrone A; Riganelli L; Savone D; Casorelli A; Merlino L; Pecorini F; Pecorella I; Mancino P; Piccioni MG; Benedetti Panici P
Tumori; 2017 Nov; 103(6):511-515. PubMed ID: 28574130
[TBL] [Abstract][Full Text] [Related]
23. New molecular tools for efficient screening of cervical cancer.
von Knebel Doeberitz M
Dis Markers; 2001; 17(3):123-8. PubMed ID: 11790875
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of telomerase in cervical lesions: a systematic review.
Rosa MI; Medeiros LR; Bozzetti MC; Fachel J; Wendland E; Zanini RR; Moraes AB; Rosa DD
Int J Gynecol Cancer; 2007; 17(6):1205-14. PubMed ID: 17506842
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of overexpressed p16INK4a in patients with cervical cancer: a meta-analysis.
Lin J; Albers AE; Qin J; Kaufmann AM
PLoS One; 2014; 9(9):e106384. PubMed ID: 25188353
[TBL] [Abstract][Full Text] [Related]
26. Eosinophilic dysplasia of the cervix associated with HPV 6 infection - case report and review of the literature.
Ondič O; Kašpírková J; Ferko R
Cesk Patol; 2013 Oct; 49(4):146-8. PubMed ID: 24289485
[TBL] [Abstract][Full Text] [Related]
27. Status quo and prevention of overtreatment in cervical diseases.
Tianmin X; Weiqin C; Manhua C; Yang L; Lihui S; Tianshu W; Xiaocui L
Eur J Gynaecol Oncol; 2012; 33(3):300-3. PubMed ID: 22873104
[TBL] [Abstract][Full Text] [Related]
28. [The p16INK4A mRNA transcripts estimation in cervical smear with different degrees of cervical dysplasia].
Janušicová V; Kapustová I; Zúbor P; Slezák P; Kajo K; Lasabová Z; Plank L; Danko J
Ceska Gynekol; 2012 Jun; 77(3):245-50. PubMed ID: 22779728
[TBL] [Abstract][Full Text] [Related]
29. [Cell protein p16INK4a hyperexpression in epithelial malignancies induced by human papillomaviruses].
Volgareva GM; Zavalishina LE; Andreeva IuIu; Shtil' AA; Frank GA
Arkh Patol; 2008; 70(5):57-61. PubMed ID: 19137788
[TBL] [Abstract][Full Text] [Related]
30. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
31. p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia.
Kalof AN; Cooper K
Adv Anat Pathol; 2006 Jul; 13(4):190-4. PubMed ID: 16858153
[TBL] [Abstract][Full Text] [Related]
32. Management of HPV-related cervical disease: role of p16INK4a immunochemistry. Review of the literature.
Savone D; Carrone A; Riganelli L; Merlino L; Mancino P; Benedetti Panici P
Tumori; 2016 Oct; 102(5):450-458. PubMed ID: 27443891
[TBL] [Abstract][Full Text] [Related]
33. P16INK4a immunocytochemistry/immunohistochemistry: need for scoring uniformization to be clinically useful in gynecological pathology.
van Bogaert LJ
Ann Diagn Pathol; 2012 Oct; 16(5):422-6. PubMed ID: 22537665
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
